TCT 269: Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- lecture fees